Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2024)Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.
Sectors & IndustriesHealthcare
Sector: Healthcare
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| EVOK | EVOKE PHARMA INC | United States | $4.04M | 8,597,405 | 21.02% | 78.98% | ||
| TARO | TARO PHARMACEUTICAL INDUSTRIES LTD | Israel | $1.59B | 37,587,231 | 12.41% | 50.73% | ||
| CATX | PERSPECTIVE THERAPEUTICS INC | United States | $952.62M | 622,629,038 | 39.76% | 19.78% | Net Buying | Net Buying |
| SABS | SAB BIOTHERAPEUTICS INC | United States | $35.70M | 9,225,494 | 6.01% | 93.99% | Net Buying | |
| PRGO | PERRIGO CO PLC | Ireland | $4.10B | 136,320,433 | 61.28% | 38.72% | Net Buying | Net Buying |
| FEMY | FEMASYS INC | United States | $28.66M | 22,220,718 | 6.63% | 8.01% | ||
| WRBY | WARBY PARKER INC | United States | $1.92B | 118,862,327 | 48.80% | 51.20% | Net Selling | Net Selling |
| ACST | ACASTI PHARMA INC | Canada | $25.94M | 9,399,404 | 13.46% | 64.72% | Net Buying | |
| TMCI | TREACE MEDICAL CONCEPTS INC | United States | $349.11M | 62,008,135 | 51.21% | 48.79% | Net Selling | Net Buying |
| LSTA | LISATA THERAPEUTICS INC | United States | $23.39M | 8,307,433 | 0.84% | 99.16% | Net Selling | |
| QLI | QILIAN INTERNATIONAL HOLDING GROUP LTD | China | $25.60M | 35,750,000 | 0.11% | 0.00% | ||
| SUPN | SUPERNUS PHARMACEUTICALS INC | United States | $1.60B | 54,974,254 | 45.05% | 54.95% | Net Selling | Net Selling |
| LVTX | LAVA THERAPEUTICS NV | Netherlands | $72.56M | 26,289,087 | 14.31% | 0.00% | ||
| COGT | COGENT BIOSCIENCES INC | United States | $714.23M | 95,613,396 | 90.30% | 9.70% | Net Buying | |
| AZTR | AZITRA INC | United States | $5.70M | 28,804,643 | 5.24% | 55.13% | Net Buying | Net Buying |
| SLDB | SOLID BIOSCIENCES INC | United States | $356.93M | 38,379,413 | 36.75% | 63.25% | Net Buying | Net Selling |
| COCP | COCRYSTAL PHARMA INC | United States | $19.99M | 10,173,790 | 0.73% | 99.27% | ||
| VCEL | VERICEL CORP | United States | $2.31B | 48,601,736 | 90.94% | 9.06% | Net Selling | Net Selling |
| NVNO | ENVVENO MEDICAL CORP | United States | $65.98M | 13,330,000 | 24.55% | 75.45% | Net Buying | Net Buying |
| EKSO | EKSO BIONICS HOLDINGS INC | United States | $26.35M | 18,174,426 | 5.61% | 94.39% | Net Selling | |
| RXRX | RECURSION PHARMACEUTICALS INC | United States | $2.26B | 237,663,668 | 75.59% | 24.41% | Net Selling | Net Selling |
| RLMD | RELMADA THERAPEUTICS INC | United States | $105.31M | 30,174,202 | 47.42% | 3.43% | Net Buying | |
| KRRO | KORRO BIO INC | United States | $475.33M | 9,272,987 | 19.69% | 80.31% | Net Buying | Net Buying |
| TNGX | TANGO THERAPEUTICS INC | United States | $832.33M | 106,846,262 | 60.61% | 39.39% | Net Buying | Net Selling |
| CLVR | CLEVER LEAVES HOLDINGS INC | United States | $5.26M | 1,754,795 | 0.96% | 99.04% | Net Selling | Net Selling |
| SLNO | SOLENO THERAPEUTICS INC | United States | $1.53B | 33,411,329 | 22.87% | 77.13% | Net Buying | Net Selling |
| TENX | TENAX THERAPEUTICS INC | United States | $6.95M | 1,958,245 | 0.04% | 99.96% | ||
| LFST | LIFESTANCE HEALTH GROUP INC | United States | $2.82B | 382,287,766 | 33.46% | 66.54% | Net Selling | Net Selling |
| ACHV | ACHIEVE LIFE SCIENCES INC | United States | $174.11M | 34,341,303 | 47.89% | 27.71% | Net Buying | Net Selling |
| GDRX | GOODRX HOLDINGS INC | United States | $3.02B | 375,205,112 | 34.31% | 11.18% | Net Selling | Net Selling |
| KTRA | KINTARA THERAPEUTICS INC | United States | $8.02M | 55,304,613 | 0.90% | 19.69% | ||
| FWBI | FIRST WAVE BIOPHARMA INC | United States | $7.33M | 2,475,090 | 0.71% | 99.29% | Net Selling | Net Selling |
| ABOS | ACUMEN PHARMACEUTICALS INC | United States | $224.10M | 60,079,778 | 72.18% | 16.58% | Net Buying | |
| ALDX | ALDEYRA THERAPEUTICS INC | United States | $243.01M | 59,414,489 | 59.59% | 33.90% | Net Selling | Net Buying |
| MDGL | MADRIGAL PHARMACEUTICALS INC | United States | $4.63B | 21,311,526 | 23.84% | 76.16% | Net Buying | Net Buying |
| ERAS | ERASCA INC | United States | $320.71M | 173,358,966 | 41.93% | 49.54% | Net Buying | |
| AUGX | AUGMEDIX INC | United States | $60.23M | 48,967,729 | 34.51% | 65.49% | Net Buying | Net Selling |
| ANAB | ANAPTYSBIO INC | United States | $695.81M | 27,318,644 | 41.15% | 58.85% | Net Selling | Net Selling |
| SNPX | SYNAPTOGENIX INC | United States | $6.06M | 1,233,230 | 72.93% | 21.82% | ||
| ELVN | ENLIVEN THERAPEUTICS INC | United States | $1.12B | 47,036,698 | 49.49% | 50.51% | Net Selling | Net Selling |
| HSCS | HEART TEST LABORATORIES INC | United States | $7.41M | 65,561,630 | 2.37% | 1.37% | ||
| PRME | PRIME MEDICINE INC | United States | $845.02M | 120,030,813 | 39.78% | 60.22% | Net Buying | |
| NAUT | NAUTILUS BIOTECHNOLOGY INC | United States | $365.77M | 125,265,015 | 40.57% | 59.43% | Net Buying | Net Buying |
| CCLD | CARECLOUD INC | United States | $40.46M | 16,120,767 | 9.22% | 46.13% | Net Buying | Net Selling |
| ESPR | ESPERION THERAPEUTICS INC | United States | $490.70M | 189,460,293 | 66.12% | 20.74% | Net Selling | |
| NVRO | NEVRO CORP | United States | $410.26M | 36,728,648 | 72.74% | 27.26% | Net Selling | Net Selling |
| ENTX | ENTERA BIO LTD | Israel | $93.04M | 35,785,309 | 11.84% | 3.76% | Net Buying | |
| GDTC | CYTOMED THERAPEUTICS LTD | Singapore | $24.58M | 11,540,000 | 0.00% | 57.45% | ||
| IPA | IMMUNOPRECISE ANTIBODIES LTD | Canada | $29.47M | 26,315,260 | 6.36% | 0.00% | ||
| FNA | PARAGON 28 INC | United States | $661.12M | 82,951,360 | 18.06% | 81.94% | Net Selling | Net Buying |
| CDTX | CIDARA THERAPEUTICS INC | United States | $54.74M | 4,561,708 | 60.41% | 39.59% | Net Selling | Net Selling |
| RNAC | CARTESIAN THERAPEUTICS INC | United States | $468.75M | 17,796,053 | 54.76% | 45.24% | Net Buying | Net Buying |
| TRML | TOURMALINE BIO INC | United States | $384.70M | 25,646,509 | 54.37% | 45.63% | Net Selling | |
| CNTB | CONNECT BIOPHARMA HOLDINGS LTD | China | $94.78M | 55,102,954 | 7.16% | 0.00% | ||
| CHEK | CHECK-CAP LTD | Israel | $13.09M | 5,850,770 | 0.11% | 0.00% | ||
| NKTX | NKARTA INC | United States | $480.59M | 70,467,620 | 64.47% | 35.53% | Net Buying | Net Buying |
| RDNT | RADNET INC | United States | $4.25B | 73,880,145 | 67.02% | 32.98% | Net Selling | |
| PACB | PACIFIC BIOSCIENCES OF CALIFORNIA INC | United States | $596.46M | 272,355,892 | 92.59% | 7.41% | Net Buying | Net Buying |
| VRNA | VERONA PHARMA PLC | United Kingdom | $1.08B | 648,654,174 | 10.26% | 55.71% | Net Selling | Net Selling |
| XRTX | XORTX THERAPEUTICS INC | Canada | $4.70M | 1,998,848 | 0.83% | 0.00% | ||
| ELYM | ELIEM THERAPEUTICS INC | United States | $237.97M | 29,091,166 | 57.94% | 22.46% | Net Buying | |
| XRAY | DENTSPLY SIRONA INC | United States | $5.89B | 207,630,556 | 97.77% | 2.23% | Net Selling | Net Selling |
| CDNA | CAREDX INC | United States | $769.80M | 52,083,792 | 78.99% | 21.01% | Net Selling | Net Buying |
| STRO | SUTRO BIOPHARMA INC | United States | $339.45M | 81,794,334 | 65.22% | 18.25% | Net Selling | Net Selling |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | United States | $3.11B | 124,200,230 | 76.41% | 10.68% | Net Selling | Net Selling |
| BLFS | BIOLIFE SOLUTIONS INC | United States | $1.01B | 46,030,886 | 58.35% | 41.65% | Net Buying | Net Selling |
| ADPT | ADAPTIVE BIOTECHNOLOGIES CORP | United States | $548.21M | 147,368,324 | 61.88% | 38.12% | Net Selling | Net Selling |
| MRUS | MERUS NV | Netherlands | $2.64B | 58,687,551 | 87.00% | 13.00% | Net Selling | |
| NEUE | NEUEHEALTH INC | United States | $50.33M | 8,224,541 | 4.91% | 95.09% | Net Selling | Net Selling |
| PSNL | PERSONALIS INC | United States | $72.45M | 51,938,839 | 42.83% | 17.87% | Net Selling | Net Buying |
| NTBL | NOTABLE LABS LTD | Israel | $9.38M | 9,018,261 | 2.95% | 97.05% | Net Selling | |
| ONVO | ORGANOVO HOLDINGS INC | United States | $10.44M | 10,040,074 | 4.83% | 95.17% | Net Selling | |
| APLS | APELLIS PHARMACEUTICALS INC | United States | $5.10B | 121,365,555 | 74.59% | 25.41% | Net Buying | Net Selling |
| SGMO | SANGAMO THERAPEUTICS INC | United States | $126.37M | 207,510,076 | 48.65% | 15.51% | Net Selling | Net Selling |
| TNXP | TONIX PHARMACEUTICALS HOLDING CORP | United States | $17.39M | 95,543,805 | 12.56% | 16.26% | ||
| RGNX | REGENXBIO INC | United States | $788.59M | 49,255,966 | 78.01% | 21.99% | Net Selling | Net Buying |
| OMGA | OMEGA THERAPEUTICS INC | United States | $131.27M | 55,154,985 | 58.18% | 41.82% | Net Selling | |
| DYAI | DYADIC INTERNATIONAL INC | United States | $48.53M | 29,236,814 | 8.00% | 92.00% | ||
| RMTI | ROCKWELL MEDICAL INC | United States | $52.75M | 30,315,684 | 14.41% | 85.59% | Net Selling | Net Selling |
| TELA | TELA BIO INC | United States | $156.81M | 24,655,371 | 47.41% | 52.59% | Net Selling | Net Selling |
| ALEC | ALECTOR INC | United States | $529.15M | 96,384,562 | 61.66% | 38.34% | Net Selling | Net Selling |
| SONN | SONNET BIOTHERAPEUTICS HOLDINGS INC | United States | $5.76M | 3,112,401 | 1.08% | 98.92% | Net Buying | |
| PSTX | POSEIDA THERAPEUTICS INC | United States | $324.32M | 96,957,650 | 54.38% | 40.40% | Net Selling | Net Selling |
| CLNN | CLENE INC | United States | $49.58M | 128,433,721 | 5.68% | 52.66% | Net Buying | Net Selling |
| AFMD | AFFIMED NV | Germany | $82.84M | 15,227,463 | 17.79% | 0.00% | ||
| QTTB | Q32 BIO INC | United States | $370.21M | 11,942,129 | 26.61% | 73.39% | Net Selling | Net Selling |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | United States | $2.92B | 279,832,722 | 16.63% | 83.37% | Net Buying | Net Buying |
| APYX | APYX MEDICAL CORP | United States | $53.01M | 34,643,926 | 37.70% | 24.04% | Net Buying | |
| MRNS | MARINUS PHARMACEUTICALS INC | United States | $71.41M | 54,933,774 | 81.92% | 18.08% | Net Buying | Net Buying |
| SCPH | SCPHARMACEUTICALS INC | United States | $173.96M | 36,054,409 | 55.04% | 44.96% | Net Selling | |
| LUMO | LUMOS PHARMA INC | United States | $21.35M | 8,116,488 | 16.51% | 83.49% | Net Buying | Net Buying |
| ORGS | ORGENESIS INC | United States | $18.23M | 34,338,782 | 4.02% | 95.98% | Net Buying | Net Buying |
| CDIO | CARDIO DIAGNOSTICS HOLDINGS INC | United States | $19.03M | 22,685,589 | 7.15% | 32.68% | Net Buying | Net Buying |
| BCYC | BICYCLE THERAPEUTICS PLC | United Kingdom | $948.84M | 42,779,030 | 53.87% | 46.13% | Net Selling | Net Selling |
| ABEO | ABEONA THERAPEUTICS INC | United States | $189.46M | 41,186,004 | 26.16% | 73.84% | Net Buying | Net Buying |
| ACHC | ACADIA HEALTHCARE COMPANY INC | United States | $6.18B | 92,774,604 | 65.57% | 34.43% | Net Selling | Net Selling |
| LIPO | LIPELLA PHARMACEUTICALS INC | United States | $5.80M | 7,605,636 | 4.99% | 23.36% | Net Buying | Net Buying |
| DCTH | DELCATH SYSTEMS INC | United States | $193.39M | 27,785,803 | 30.05% | 43.34% | Net Buying | Net Buying |
| LEXX | LEXARIA BIOSCIENCE CORP | Canada | $40.46M | 12,885,673 | 6.90% | 4.82% | Net Buying | Net Buying |
| STIM | NEURONETICS INC | United States | $75.59M | 29,997,563 | 52.75% | 47.25% | Net Selling | Net Selling |
Healthcare Industries
| Industry | Stocks | 1d % | 1w % | 1m % | 1y % | Zen Score | P/E ratio | P/B Ratio | ROE | ROA | ROCE | Upside/Downside | Consensus |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 679 | -0.04% | +0.91% | +3.56% | -18.59% | 8.43x | 6.06x | +18.39% | +3.73% | -27.83% | +76.96% | Strong Buy | ||
| 64 | -0.44% | +7.25% | +11.82% | +11.92% | 38.80x | 4.48x | -13.29% | +6.45% | +11.46% | +4.67% | Buy | ||
| 18 | -1.13% | +1.15% | +7.58% | +17.63% | 31.18x | 6.42x | +33.58% | +8.09% | +14.21% | +10.87% | Buy | ||
| 88 | +0.20% | +1.16% | +5.36% | -1.14% | -1.18x | 2.20x | +12.32% | +3.31% | +5.98% | +31.51% | Strong Buy | ||
| 12 | +0.46% | +1.09% | +5.04% | +5.89% | 25.41x | 3.05x | +15.18% | +4.74% | +11.78% | +12.50% | Buy | ||
| 61 | +0.42% | +0.73% | -1.16% | -19.05% | 5.93x | 3.31x | +6.57% | +2.11% | +5.22% | +27.52% | Buy | ||
| 51 | -1.02% | +0.20% | +4.10% | +11.73% | 40.97x | 4.60x | -92.21% | +6.56% | +13.62% | +14.66% | Buy | ||
| 150 | -0.36% | +1.22% | +1.80% | -12.40% | 30.63x | 4.00x | +7.26% | +5.26% | +8.15% | +19.56% | Buy | ||
| 10 | +0.42% | +0.06% | -0.15% | +26.26% | 26.60x | 106.30x | -10.85% | +3.43% | +19.53% | +10.05% | Buy | ||
| 56 | -1.50% | +2.24% | +5.10% | -6.26% | 59.50x | 3.63x | +11.22% | +7.71% | +10.03% | +17.89% | Buy |
Healthcare Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.